All posts by: Michael Zand

About Michael Zand

Stem cells may speed up screening of drugs for rare cancers – Science Codex

Continue reading

2016-08-03 NEWS

Stem cells may speed up screening of drugs for rare cancers
Science Codex
1 issue of Clinical Cancer Research, describes experiments that transform human stem cells into an aggressive and rare form of pediatric brain cancer called medulloblastoma. Those cancer cells’ genetic profiles can then be rapidly compared with

and more »

Continue reading

2016-08-03 NEWS

Thanh Nien Daily

Vietnam doctors train Cambodians in hematopoietic stem cell transplant
Thanh Nien Daily
The Ho Chi Minh City Blood Transfusion Hematology Hospital has begun a training course in hematopoietic stem cell transplant for Cambodia’s Calmette Hospital. Dr Sok Sothea of Calmette said a team of three doctors, two nurses and a technician would …

Continue reading

2016-08-03 NEWS

PharmaTimes

Takeda/Tigenix’ stem cell therapy hits targets in Crohn’s trial
PharmaTimes
Takeda and TiGenix’ stem cell therapy has shown promise in inducing remission of perianal fistulas in patients with Crohn’s disease, according findings of a late-stage trial published in The Lancet. The Phase III ADMIRE-CD trial assessed the safety and …

and more »

Continue reading

2016-08-02 NEWS

Stem Cell Tx Evaluated for Perianal Fistulas in Crohn’s Disease
Monthly Prescribing Reference (registration)
Takeda and TiGenix announced positive results from the Phase 3 ADMIRE-CD trial of Cx601 for the treatment of complex perianal fistulas in patients with Crohn’s disease. Study findings were published in The Lancet. ADMIRE-CD was a 24-week, randomized …

and more »